SCHEMBL23947829

SCHEMBL23947829

c1ccc(-c2ccc3c(c2)c2ccc(-c4ccc5c(c4)oc4ccc(-c6nc(-c7ccccc7)nc(-c7cccc8oc9ccccc9c78)n6)cc45)cc2n3-c2ccccc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
PLA2G2A P14555 2/20 0.32
PLA2G4A P47712 2/20 0.32
MMP12 P39900 1/20 0.32
MMP13 P45452 1/20 0.32
PLA2G10 O15496 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PTGER4 P35408 2/20 0.30
PIM1 P11309 1/20 0.30
CSNK2A2 P19784 1/20 0.30
CSNK2B P67870 1/20 0.30
PIM3 Q86V86 1/20 0.30
PIM2 Q9P1W9 1/20 0.30
CHEK2 O96017 1/20 0.30
HCRTR1 O43613 1/20 0.30
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26169017 0.97 PLA2G2A (0.33) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL26169222 0.97 PLA2G2A (0.33) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL26168517 0.97 PLA2G2A (0.33) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL26168754 0.97 SIRT2 (0.31) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL23947830 0.97 PLA2G2A (0.34) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL26168497 0.97 PLA2G2A (0.34) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL23814075 0.96 PLA2G2A (0.33) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL23947889 0.96 KDM4E (0.35) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL21187385 0.96 KDM4E (0.35) SIRT2SIRT1PLA2G2APLA2G4AMMP12
SCHEMBL23947827 0.96 KDM4E (0.35) SIRT2SIRT1PLA2G2APLA2G4AMMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-11873297-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2024-01-16 US disclosed
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210323948-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CCNL2, UBE2L3, OPRL1 SIRT2 924/4885SIRT1 1253/4885PLA2G2A 3489/4885
US-11873297-B2 Compound and organic light emitting device comprising the same CCNL2, UBE2L3, ARL1 SIRT2 875/4885SIRT1 1239/4885PLA2G2A 3492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.